FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2321831128> ?p ?o ?g. }

• W2321831128 endingPage "e0152982" @default.
• W2321831128 startingPage "e0152982" @default.
• W2321831128 abstract "Emerging evidence suggests that DNAM-1 (CD226) play an important role in the recognition of tumor cells and their lysis by cytotoxic T lymphocytes (CTL) and NK cells. Although the DNAM-1 ligand CD155 is ubiquitously expressed in various tissues, many human tumors significantly upregulate the expression of CD155; DNAM-1 on CTL and NK cells may be involved in tumor immunity. However, unlike those in mice, human tissues also express soluble isoforms of CD155 (sCD155) that lack the transmembrane region. Here, we show that sCD155 levels were significantly higher in the sera of 262 patients with lung, gastrointestinal, breast, and gynecologic cancers than in sera from healthy donors. In addition, the sCD155 levels were significantly higher in patients with early stage (stages 1 and 2) gastric cancer than in healthy donors, and were significantly higher in patients with advanced stage (stages 3 and 4) disease than in patients in those with early stage disease and healthy donors. Moreover, the sCD155 levels were significantly decreased after surgical resection of cancers. Thus, sCD155 level in serum may be potentially useful as a biomarker for cancer development and progression." @default.
• W2321831128 created "2016-06-24" @default.
• W2321831128 creator A5018049490 @default.
• W2321831128 creator A5018279362 @default.
• W2321831128 creator A5026508252 @default.
• W2321831128 creator A5028795531 @default.
• W2321831128 creator A5047573951 @default.
• W2321831128 creator A5049550015 @default.
• W2321831128 creator A5062574029 @default.
• W2321831128 creator A5064741366 @default.
• W2321831128 creator A5065838242 @default.
• W2321831128 creator A5083746251 @default.
• W2321831128 creator A5088519518 @default.
• W2321831128 date "2016-04-06" @default.
• W2321831128 modified "2023-10-01" @default.
• W2321831128 title "Increased Soluble CD155 in the Serum of Cancer Patients" @default.
• W2321831128 cites W1240690053 @default.
• W2321831128 cites W1552754679 @default.
• W2321831128 cites W1560624221 @default.
• W2321831128 cites W1634951127 @default.
• W2321831128 cites W1966808339 @default.
• W2321831128 cites W1968412062 @default.
• W2321831128 cites W1972814015 @default.
• W2321831128 cites W1976152961 @default.
• W2321831128 cites W1978614011 @default.
• W2321831128 cites W1981352048 @default.
• W2321831128 cites W2007825988 @default.
• W2321831128 cites W2014349052 @default.
• W2321831128 cites W2048253455 @default.
• W2321831128 cites W2050457398 @default.
• W2321831128 cites W2052313621 @default.
• W2321831128 cites W2060813234 @default.
• W2321831128 cites W2064706501 @default.
• W2321831128 cites W2064920472 @default.
• W2321831128 cites W2072598572 @default.
• W2321831128 cites W2073303594 @default.
• W2321831128 cites W2083616674 @default.
• W2321831128 cites W2099126386 @default.
• W2321831128 cites W2103028860 @default.
• W2321831128 cites W2104794630 @default.
• W2321831128 cites W2118146259 @default.
• W2321831128 cites W2121626779 @default.
• W2321831128 cites W2129673110 @default.
• W2321831128 cites W2142594520 @default.
• W2321831128 cites W2143731593 @default.
• W2321831128 cites W2144201925 @default.
• W2321831128 cites W2147443000 @default.
• W2321831128 cites W2149312162 @default.
• W2321831128 cites W2159896657 @default.
• W2321831128 cites W2166970460 @default.
• W2321831128 cites W2167081611 @default.
• W2321831128 cites W2168459600 @default.
• W2321831128 cites W2171709048 @default.
• W2321831128 cites W2560367415 @default.
• W2321831128 cites W4249144791 @default.
• W2321831128 cites W87599195 @default.
• W2321831128 doi "https://doi.org/10.1371/journal.pone.0152982" @default.
• W2321831128 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4822883" @default.
• W2321831128 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27049654" @default.
• W2321831128 hasPublicationYear "2016" @default.
• W2321831128 type Work @default.
• W2321831128 sameAs 2321831128 @default.
• W2321831128 citedByCount "77" @default.
• W2321831128 countsByYear W23218311282016 @default.
• W2321831128 countsByYear W23218311282017 @default.
• W2321831128 countsByYear W23218311282018 @default.
• W2321831128 countsByYear W23218311282019 @default.
• W2321831128 countsByYear W23218311282020 @default.
• W2321831128 countsByYear W23218311282021 @default.
• W2321831128 countsByYear W23218311282022 @default.
• W2321831128 countsByYear W23218311282023 @default.
• W2321831128 crossrefType "journal-article" @default.
• W2321831128 hasAuthorship W2321831128A5018049490 @default.
• W2321831128 hasAuthorship W2321831128A5018279362 @default.
• W2321831128 hasAuthorship W2321831128A5026508252 @default.
• W2321831128 hasAuthorship W2321831128A5028795531 @default.
• W2321831128 hasAuthorship W2321831128A5047573951 @default.
• W2321831128 hasAuthorship W2321831128A5049550015 @default.
• W2321831128 hasAuthorship W2321831128A5062574029 @default.
• W2321831128 hasAuthorship W2321831128A5064741366 @default.
• W2321831128 hasAuthorship W2321831128A5065838242 @default.
• W2321831128 hasAuthorship W2321831128A5083746251 @default.
• W2321831128 hasAuthorship W2321831128A5088519518 @default.
• W2321831128 hasBestOaLocation W23218311281 @default.
• W2321831128 hasConcept C121608353 @default.
• W2321831128 hasConcept C126322002 @default.
• W2321831128 hasConcept C147969180 @default.
• W2321831128 hasConcept C154317977 @default.
• W2321831128 hasConcept C167672396 @default.
• W2321831128 hasConcept C202751555 @default.
• W2321831128 hasConcept C203014093 @default.
• W2321831128 hasConcept C2781197716 @default.
• W2321831128 hasConcept C502942594 @default.
• W2321831128 hasConcept C530470458 @default.
• W2321831128 hasConcept C55493867 @default.
• W2321831128 hasConcept C71924100 @default.
• W2321831128 hasConcept C86803240 @default.
• W2321831128 hasConcept C8891405 @default.

• next